Rolipram is an investigational drug.
There have been 9 clinical trials for Rolipram.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2001.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, Major, and Depressive Disorder. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS), and Dart NeuroScience, LLC.